Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 19Leukemia 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 16Myelodysplastic Syndromes 14Lymphoma 11Multiple Myeloma 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Leukemia, Lymphocytic, Chronic, B-Cell 7Lymphoma, Non-Hodgkin 6Leukemia, Biphenotypic, Acute 5Hodgkin Disease 5Neuroblastoma 4Hematologic Neoplasms 4Hematologic Diseases 4Sarcoma, Ewing 3Rhabdomyosarcoma 3Neoplasms, Plasma Cell 3Lymphoma, Follicular 3Graft vs Host Disease 3Congenital Abnormalities 3Burkitt Lymphoma 3Brain Neoplasms 3Wilms Tumor 2Waldenstrom Macroglobulinemia 2Testicular Neoplasms 2Sarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Myeloproliferative Disorders 2Medulloblastoma 2Lymphoma, T-Cell, Cutaneous 2

Interventions

Rituximab 4Etoposide 4Cyclophosphamide 4Vincristine 3Prednisone 3Doxorubicin 3liposomal doxorubicin 2varlilumab 1prednylidene 1pomalidomide 1fialuridine 1etoposide phosphate 1deltacortene 1Vorinostat 1Ultrasonography 1Salvia hispanica seed extract 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Lenalidomide 1Immunoglobulin G 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Endoscopy 1Electrocardiography 1Echocardiography 1Disulfides 1Cytarabine 1Carmustine 1CT-P10 1Bronchoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lymphoma, Primary Effusion × Bone Marrow Transplantation × Clear all
NCT04975698 2026-03-25

BMTCTN1903

National Heart, Lung, and Blood Institute (NHLBI)

Phase 2 Completed
12 enrolled
Lymphoid

Lymphoma, Primary Effusion

Data powered by HemOnc (CC BY 4.0) Colophon âš¡